Pharmas, Web 2.0 and regulation
For a change – ethics based regulation that differentiates between the medium and the message. Dr. Jean Ah Kang, works at DDMAC and is in charge of Web 2.0 policy development. She speaks very well at her interview with Mark Senak, a regulatory affairs lawyer ( eyeonfda.com ). Here is the podcast: FDA’s views and […]
